Form 4: Executive Exercises Options and Sells Shares

Serina Therapeutics, Inc.'s Chief Scientific Officer, Randall Moreadith, exercised stock options and subsequently sold the acquired common stock.

Summary

• Randall Moreadith, Chief Scientific Officer of Serina Therapeutics, Inc., exercised 6,500 stock options on July 14, 2025, at an exercise price of $0.06 per share.
• Concurrently, Moreadith sold all 6,500 shares of common stock acquired from the option exercise at a weighted average price of $5.01 per share.
• The sale price for these shares ranged from $5.00 to $5.91 per share.
• Following these transactions, the reporting person's direct beneficial ownership of the sold common stock is 0 shares, while 501,686 stock options remain beneficially owned.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While insider selling can sometimes be viewed negatively, this is a standard option exercise and sale, indicating the executive is monetizing vested compensation. The significant profit realized is positive for the executive.

Positives

• The Chief Scientific Officer realized a significant profit by exercising options at $0.06 and selling shares at an average of $5.01.
• The stock options were fully vested, indicating the executive had met the conditions for exercising them.

Negatives

• The sale of shares by a Chief Scientific Officer could be interpreted by some investors as a lack of confidence in the company's near-term stock performance, although it is a common practice for executives to monetize vested options.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of an insider transaction, common across all industries for publicly traded companies when executives exercise options and sell shares. It does not provide specific industry-related insights beyond the company's name.

Related Party Transactions

• Randall Moreadith, Chief Scientific Officer, engaged in a transaction involving the exercise of stock options and subsequent sale of common stock, which is a related party transaction by definition as it involves an executive of the company.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive could potentially lead to short-term negative sentiment or increased selling pressure, though it's a common practice for executives to monetize vested options.

Key Dates

Recommendation

Keywords

Insider Trading, Stock Option Exercise, Share Sale, Executive Compensation, SEC Form 4, Serina Therapeutics